It's clear to me the transaction was facilitated on behalf of a to-be-named institutional investor. It's unfortunate Alan misinterpreted the message.
From the article, Alan didn't mention that OWCP is required to file a S-1 registration statement so the shares going to the unnamed company are immediately free trading.
From the article:
"OWC Pharmaceutical, based in Israel, issued a very bullish sounding press release last week, indicating it had raised $5 million from an institutional investor. First, to call Newbridge Securities an "institutional investor" is a bit of a stretch, as it is one of the several sharks that feed on struggling OTC companies."